Tempest Therapeutics (TPST) Shares Outstanding (2011 - 2026)

Tempest Therapeutics has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $4.9 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 129.58% year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (up 129.58% YoY) and the FY2025 annual result came in at $4.9 million, up 129.58% from the prior year.
• Shares Outstanding (Entity) advanced to $4.9 million in Q4 2025 per TPST's latest filing, from $4.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $4.9 million in Q4 2025 and troughed at $71184.0 in Q2 2021.
• A 5-year average of $1.7 million and a median of $1.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) dropped 26.94% in 2021, then soared 1015.74% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $291550.0 in 2021, then surged by 177.51% to $809086.0 in 2022, then surged by 46.56% to $1.2 million in 2023, then jumped by 80.99% to $2.1 million in 2024, then surged by 129.58% to $4.9 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $4.9 million, $4.4 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.